Determinants of variations in initial treatment strategies for stable ischemic heart disease

CMAJ

Volumn 187, Issue 10, 2015, Pages E317-E325

  Bennell, Maria C ^a   Qiu, Feng ^c   Kingsbury, Kori J ^d   Austin, Peter C ^b,c   Wijeysundera, Harindra C ^a,b,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d Cardiac Care Network of Ontario   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION RATIO; SMOKING; AGE; ANGINA, STABLE; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; EXERCISE TEST; FACTUAL DATABASE; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HYPERLIPIDEMIAS; HYPERTENSION; INCOME; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTILIZATION;

CARDIOVASCULAR AGENT;

AGE FACTORS; AGED; ANGINA, STABLE; CARDIOVASCULAR AGENTS; COHORT STUDIES; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DATABASES, FACTUAL; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HOSPITALS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INCOME; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; ONTARIO; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASES; PRACTICE PATTERNS, PHYSICIANS'; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84937427489     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.141372     Document Type: Article

References (26)

1. Cardiovascular diseases (CVDs). Geneva: World Health Organization. Available: www.who.int/mediacentre/factsheets/fs317/en/ (updated January 2015; accessed 2015 Apr. 24).
2. Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA 2010;303:1841-7.
3. Cannon CP, Waheed S. Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelines. Rev Cardiovasc Med 2009;10(Suppl 1):S21-9.
4. Opie LH, Commerford PJ, Gersh BJ. Controversies in stable coronary artery disease. Lancet 2006;367:69-78.
5. Simoons ML, Windecker S. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J 2010;31:530-41.
6. Boden WE, O'Rourke RA, Teo KK, et al. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol 2009;104:1-4.
7. Breeman A, Hordijk-Trion M, Lenzen M, et al. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization. J Thorac Cardiovasc Surg 2006;132:1001-9.
8. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.
9. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Circulation 2009;119:1330-52.
10. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA 2011;306:53-61.
11. Ko DT, Tu JV, Austin PC, et al. Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario. JAMA 2013;310:163-9.
12. Ko DT, Tu JV, Samadashvili Z, et al. Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation 2010;121:2635-44.
13. Tu JV, Ko DT, Guo H, et al. Determinants of variations in coronary revascularization practices. CMAJ 2012;184:179-86.
14. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-41.
15. About the Cardiac Care Network of Ontario. Toronto: Cardiac Care Network; 2009. Available: www.ccn.on.ca/ccn-public/FormsAboutCCN/about.aspx (accessed 2015 May 1).
16. Annual report 2001-2012. Toronto: Cardiac Care Network; 2012. Available: www.ccn.on.ca/ccn-public/uploadfiles/files/CCN-Annual-Report-2012.pdf (accessed 2015 May 1).
17. Gurevich Y, McFarlane A, Morris K, et al. Estimating the number of coronary artery bypass graft and percutaneous coronary intervention procedures in Canada: a comparison of cardiac registry and Canadian Institute for Health Information data sources. Can J Cardiol 2010;26:e249-53.
18. Wennberg DE, Birkmeyer JD, Bronner KK, et al. The quality of medical care in the United States: a report on the Medicare program. Chicago: American Heart Association Press; 1999. Available: www.dartmouthatlas.org/downloads/atlases/99Atlas.pdf (accessed 2015 Apr. 24).
19. Lucas FL, DeLorenzo MA, Siewers AE, et al. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation 2006;113:374-9.
20. Hlatky MA, DeMaria AN. Does practice variation matter? J Am Coll Cardiol 2013;62:447-8.
21. Cordero A, Bertomeu-Martinez V, Mazon P. Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther 2009;27:173-80.
22. Cram P, Rosenthal GE, Vaughan-Sarrazin MS. Cardiac revascularization in specialty and general hospitals. N Engl J Med 2005;352:1454-62.
23. Dudley RA, Johansen KL, Brand R, et al. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 2000;283:1159-66.
24. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002;137:511-20.
25. Birkmeyer JD, Dimick JB, Staiger DO. Operative mortality and procedure volume as predictors of subsequent hospital performance. Ann Surg 2006;243:411-7.
26. Hux JE, Naylor CD. Are the marginal returns of coronary artery surgery smaller in high-rate areas? The Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Lancet 1996;348:1202-7.